NCT04491786

Brief Summary

The acute pain after spinal surgery is serious. The most pain is during 24 hours after surgery. The multimodal therapy is a method which is applied to treat the postoperative pain. Morphine is main analgesic to treat postoperative pain. However, some the side-effects can occur to patients and there are associate with dosage. So, some analgesics usually combinate with morphine to postoperative analgesia, include gabapentin, celecoxib, ketamine, ... Nefopam is a central analgesic. There are effect prevent hyperalgesia. The effect of the combination of gabapentin with nefopam to postoperative analgesia in spinal surgery hasn't been reported yet. The gabapentin oral with 600 mg combine with continuously intravenous nefopam with 65 µg/kg/hour during 24 hours after spinal surgery whether to increase the effect of postoperative analgesia. The investigators hypothesized that the gabapentin oral with 600 mg combine with continuously intravenous nefopam with 65 µg/kg/hour during 24 hours after spinal surgery can decrease 40% of the consumption of morphine during 24 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 29, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

June 7, 2021

Status Verified

January 1, 2021

Enrollment Period

9 months

First QC Date

July 26, 2020

Last Update Submit

June 4, 2021

Conditions

Keywords

GabapentinNefopamSpinal surgeryPostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Consumption of morphine

    Concentration of morphine that participant use during postoperative 24 hours with PCA (mg)

    Postoperative 24 hours

Secondary Outcomes (1)

  • Side-effect

    Postoperative 24 hours

Study Arms (2)

GAPA

EXPERIMENTAL

Participants will treated with preoperative 600 mg of gabapentin plus nefopam which will continuously transfused during intraoperative and postoperative 24 hours, and morphine-PCA during postoperative 24 hours

Drug: Gabapentin

Non-GAPA

NO INTERVENTION

Participants will treated with nefopam which will continuously transfused during intraoperative and postoperative 24 hours, and morphine-PCA during postoperative 24 hours

Interventions

Gabapentin plus nefopam

Also known as: Nefopam
GAPA

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age from 18 to 70.
  • Spinal selective surgery

You may not qualify if:

  • Allergy one of drugs in study.
  • Neurological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Binh Huynh

Ho Chi Minh City, Ho Chi Minh, 70000, Vietnam

Location

MeSH Terms

Interventions

GabapentinNefopam

Intervention Hierarchy (Ancestors)

AminesOrganic Chemicalsgamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsCyclohexanecarboxylic AcidsAcids, CarbocyclicCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsAmino AcidsAmino Acids, Peptides, and ProteinsOxazocinesAzocinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Binh V. Huynh

    Nhan dan Gia Dinh Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The intervention group will treated postoperative analgesia with 600 mg of gabapentin plus 65 mcg/kg/hour during 24 hours of nefopam
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2020

First Posted

July 29, 2020

Study Start

August 1, 2020

Primary Completion

May 1, 2021

Study Completion

May 31, 2021

Last Updated

June 7, 2021

Record last verified: 2021-01

Locations